Zai Lab (ZLAB) Depreciation & Amortization (CF) (2018 - 2026)
Zai Lab (ZLAB) posted Depreciation & Amortization (CF) of $3.9 million for Q1 2026, up 0.72% sequentially from $3.9 million in Q4 2025, and up 14.05% YoY from $3.5 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Zai Lab has reported Depreciation & Amortization (CF) for 9 years, with the latest figure at $3.9 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 14.05% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.5 million (up 25.96% YoY) and the FY2025 annual result came in at $15.0 million, up 26.6% from the prior year.
- Depreciation & Amortization (CF) advanced to $3.9 million in Q1 2026 per ZLAB's latest filing, from $3.9 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $3.9 million in Q1 2026 and troughed at $1.9 million in Q2 2022.
- A 5-year average of $2.8 million and a median of $2.9 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) dropped 13.84% in 2023, then soared 49.69% in 2024.
- Over 5 years, Depreciation & Amortization (CF) stood at $2.1 million in 2022, then increased by 15.61% to $2.5 million in 2023, then grew by 23.3% to $3.0 million in 2024, then advanced by 29.16% to $3.9 million in 2025, then increased by 0.72% to $3.9 million in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $3.9 million, $3.9 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | 4.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.17 Mn |
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 3.92 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 3.74 Mn |
| Mar 31, 2025 | 3.46 Mn |
| Dec 31, 2024 | 3.03 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.94 Mn |
| Mar 31, 2024 | 3.01 Mn |
| Dec 31, 2023 | 2.46 Mn |
| Sep 30, 2023 | 1.92 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 2.66 Mn |
| Dec 31, 2022 | 2.13 Mn |
| Sep 30, 2022 | 2.23 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Mar 31, 2022 | 2.01 Mn |
| Dec 31, 2021 | 1.88 Mn |
| Sep 30, 2021 | 1.64 Mn |